Skip to main content Skip to main navigation menu Skip to site footer

Platelet-rich plasma for chronic ulcers

  • Adelia Martalova AJ ,
  • I Gusti Ayu Agung Praharsini ,
  • Alfred Setyono ,
  • Putu Akopita Devi ,
  • Indry Salonika Sutiawan ,

Abstract

Ulcers that do not heal for more than 3 months are defined as chronic ulcers. Due to their increasing morbidity and mortality rates, difficulty of treatment, psychological and financial burdens, chronic ulcers are considered as a significant health problem encountered worldwide. Dressings, compression bandages, debridement, skin grafts, and other conventional treatment modalities lack growth factors needed to modulate healing process, thus less healing along with constantly repeated treatments make the whole healing process expensive. Platelet-rich plasma (PRP) is an easy, reasonably-priced modality containing growth factors needed to increase the speed of tissue healing.

References

  1. D Kang S, Amagai M, Bruckner AL, Margolis DJ, McMichael A, Orringer J. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw-Hill; 2019.
  2. Agale SV. Chronic Leg Ulcers: Epidemiology, Aetiopathogenesis, and Management. Ulcers. 2013;2013:1–9. Available from: http://dx.doi.org/10.1155/2013/413604
  3. Huber SC, de Moraes Martinelli B, Quintero M, de Paula LÍS, Cataldo JL, de Lima Montalvão SA, et al. A case series of platelet rich plasma in chronic venous ulcers. Regen Ther. 2021;18:51–8. Available from: https://pubmed.ncbi.nlm.nih.gov/33869687
  4. San Sebastian KM, Lobato I, Hernández I, Burgos-Alonso N, Gomez-Fernandez MC, López JL, et al. Efficacy and safety of autologous platelet rich plasma for the treatment of vascular ulcers in primary care: Phase III study. BMC Fam Pract. 2014;15:211. Available from: https://pubmed.ncbi.nlm.nih.gov/25547983
  5. Szabo S, Vincze Á. Growth factors in ulcer healing: Lessons from recent studies. J Physiol. 2000;94(2):77–81. Available from: http://dx.doi.org/10.1016/s0928-4257(00)00146-7
  6. Rongioletti F, Parodi A, Rebora A. Dyshidrosiform Pemphigoid. Dermatology. 1985;170(2):84–5. Available from: http://dx.doi.org/10.1159/000249505
  7. Gade RR, M. VR, Inamdar P. A comparative study between platelet rich plasma and conventional dressing in chronic non healing leg ulcers. Int Surg J. 2020;7(3):751. Available from: http://dx.doi.org/10.18203/2349-2902.isj20200817
  8. Han G, Ceilley R. Chronic Wound Healing: A Review of Current Management and Treatments. Adv Ther. 2017/01/21. 2017;34(3):599–610. Available from: https://pubmed.ncbi.nlm.nih.gov/28108895
  9. Barron GS, Jacob SE, Kirsner RS. Dermatologic Complications of Chronic Venous Disease: Medical Management and Beyond. Ann Vasc Surg. 2007;21(5):652–62. Available from: http://dx.doi.org/10.1016/j.avsg.2007.07.002
  10. Prabhu R, Vijayakumar C, Bosco Chandra AA, Balagurunathan K, Kalaiarasi R, Venkatesan K, et al. Efficacy of Homologous, Platelet-rich Plasma Dressing in Chronic Non-healing Ulcers: An Observational Study. Cureus. 2018;10(2):e2145–e2145. Available from: https://pubmed.ncbi.nlm.nih.gov/29632754
  11. Rehman S. Management of Diabetic Foot Ulcer by Hirudo medicinalis, the “Healing Leech” [Internet]. Diabetic Foot Ulcer. Springer Singapore; 2020. p. 315–30. Available from: http://dx.doi.org/10.1007/978-981-15-7639-3_19
  12. Anders J, Heinemann A, Leffmann C, Leutenegger M, Pröfener F, von Renteln-Kruse W. Decubitus ulcers: pathophysiology and primary prevention. Dtsch Arztebl Int. 2010/05/28. 2010;107(21):371–82. Available from: https://pubmed.ncbi.nlm.nih.gov/20539816
  13. Driver VR. Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manag. 2006;52:68-87.
  14. O’Meara S, Tierney J, Cullum N, Bland JM, Franks PJ, Mole T, et al. Four layer bandage compared with short stretch bandage for venous leg ulcers: systematic review and meta-analysis of randomised controlled trials with data from individual patients. BMJ. 2009;338:b1344–b1344. Available from: https://pubmed.ncbi.nlm.nih.gov/19376798
  15. Raju S, Neglén P. Chronic Venous Insufficiency and Varicose Veins. N Engl J Med. 2009;360(22):2319–27. Available from: http://dx.doi.org/10.1056/nejmcp0802444
  16. Ramos FS, Maifrino LBM, Alves S, da Costa Aguiar Alves B, Perez MM, Feder D, et al. The effects of transcutaneous low-level laser therapy on the skin healing process: an experimental model. Lasers Med Sci. 2018;33(5):967–76. Available from: http://dx.doi.org/10.1007/s10103-017-2429-x
  17. Rusyati LMM, Suryawati NN, Karmila IGAAD. Platelet-rich fibrin (PRF) as modalities therapy of venous ulcer. Indones J Biomed Sci. 2019;13(2). Available from: http://dx.doi.org/10.15562/ijbs.v13i2.222
  18. Conde-Montero E, de la Cueva Dobao P, Martínez González JM. Platelet-rich plasma for the treatment of chronic wounds: evidence to date. Chronic Wound Care Manag Res. 2017;Volume 4:107–20. Available from: http://dx.doi.org/10.2147/cwcmr.s118655
  19. Suthar M, Gupta S, Bukhari S, Ponemone V. Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series. J Biomed Sci. 2017;24(1):16. Available from: https://pubmed.ncbi.nlm.nih.gov/28241824
  20. Rozman P, Bolta Z. Use of platelet growth factors in treating wounds and soft-tissue injuries. Acta Dermatovenerologica Alp Panon Adriat. 2007;16:156-162.
  21. Andia I, Abate M. Platelet-rich plasma: underlying biology and clinical correlates. Regen Med. 2013;8(5):645–58. Available from: http://dx.doi.org/10.2217/rme.13.59
  22. Gleissner CA, Shaked I, Little KM, Ley K. CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J Immunol. 2010/03/24. 2010;184(9):4810–8. Available from: https://pubmed.ncbi.nlm.nih.gov/20335529
  23. Abittan BJ, Goldenberg G. 1 Platelet-Rich Plasma: Mechanism and Practical Considerations [Internet]. PRP and Microneedling in Aesthetic Medicine. Georg Thieme Verlag; 2019. Available from: http://dx.doi.org/10.1055/b-0039-168439
  24. Choi J, Minn KW, Chang H. The efficacy and safety of platelet-rich plasma and adipose-derived stem cells: an update. Arch Plast Surg. 2012/11/14. 2012;39(6):585–92. Available from: https://pubmed.ncbi.nlm.nih.gov/23233882
  25. Luzo ACM, Fávaro WJ, Seabra AB, Durán N. What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review. Heliyon. 2020;6(3):e03660–e03660. Available from: https://pubmed.ncbi.nlm.nih.gov/32258495
  26. Akingboye AA, Giddins S, Gamston P, Tucker A, Navsaria H, Kyriakides C. Application of Autologous Derived-Platelet Rich Plasma Gel in the Treatment of Chronic Wound Ulcer: Diabetic Foot Ulcer. J Extracorpor Technol. 2010;42(1):20–9. Available from: http://dx.doi.org/10.1051/ject/201042020
  27. Suryawati N, Praharsini IGAA, Juliyanti J. Management Non-healing Trophic Ulcer in a Leprosy Patient with Combination of Injection and Topical Platelet Rich Plasma. J Ski Stem Cell. 2020;6(3). Available from: http://dx.doi.org/10.5812/jssc.101432
  28. Shahid M, Kundra R. Platelet-rich plasma (PRP) for knee disorders. EFORT open Rev. 2017;2(1):28–34. Available from: https://pubmed.ncbi.nlm.nih.gov/28607768
  29. O’Connell SM, Impeduglia T, Hessler K, Wang X, Carroll RJ, Dardik H. Autologous platelet‐rich fibrin matrix as cell therapy in the healing of chronic lower‐extremity ulcers. Wound Repair Regen. 2008;16(6):749–56. Available from: http://dx.doi.org/10.1111/j.1524-475x.2008.00426.x
  30. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62(4):489–96. Available from: http://dx.doi.org/10.1016/j.joms.2003.12.003
  31. M. Dohan Ehrenfest D, Bielecki T, Jimbo R, Barbe G, Del Corso M, Inchingolo F, et al. Do the Fibrin Architecture and Leukocyte Content Influence the Growth Factor Release of Platelet Concentrates? An Evidence-based Answer Comparing a Pure Platelet-Rich Plasma (P-PRP) Gel and a Leukocyte- and Platelet-Rich Fibrin (L-PRF). Curr Pharm Biotechnol. 2012;13(7):1145–52. Available from: http://dx.doi.org/10.2174/138920112800624382
  32. Dhurat R, Sukesh M. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author’s Perspective. J Cutan Aesthet Surg. 2014;7(4):189–97. Available from: https://pubmed.ncbi.nlm.nih.gov/25722595
  33. Salem A, Tawfik AM. Role of Platelet Rich Plasma in Treatment of Diabetic Foot Ulcers. Surg Sci. 2016;07(06):272–7. Available from: http://dx.doi.org/10.4236/ss.2016.76038
  34. Ficarelli E, Bernuzzi G, Tognetti E, Bussolati O, Zucchi A, Adorni D, et al. Treatment of chronic venous leg ulcers by platelet gel. Dermatol Ther. 2008;21:S13–7. Available from: http://dx.doi.org/10.1111/j.1529-8019.2008.00196.x
  35. Salemi S, Rinaldi C, Manna F, Guarneri GF, Parodi PC. Reconstruction of lower leg skin ulcer with autologous adipose tissue and platelet-rich plasma. J Plast Reconstr & Aesthetic Surg. 2008;61(12):1565–7. Available from: http://dx.doi.org/10.1016/j.bjps.2008.04.048
  36. Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med. 2010;83(1):1-9.
  37. Carter MJ, Fylling CP, Parnell LK. Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty. 2011;11:e38.
  38. Farahat A, Salah H, Al-Shraim M. Evaluation of the clinical and histopathological effect of Platelet rich plasma on chronic wound healing. Int Res J Basic Clin Stud. 2014;2:55-61.
  39. Helmy Y, Farouk N, Ali Dahy A, Abu‐Elsoud A, Fouad khattab R, Elshahat Mohammed S, et al. Objective assessment of Platelet‐Rich Plasma (PRP) potentiality in the treatment of Chronic leg Ulcer: RCT on 80 patients with Venous ulcer. J Cosmet Dermatol. 2021;20(10):3257–63. Available from: http://dx.doi.org/10.1111/jocd.14138
  40. Tsai H-C, Lehman CW, Chen C-M. Use of platelet-rich plasma and platelet-derived patches to treat chronic wounds. J Wound Care. 2019;28(1):15–21. Available from: http://dx.doi.org/10.12968/jowc.2019.28.1.15

How to Cite

Martalova AJ, A., Praharsini, I. G. A. A. ., Setyono, A. ., Devi, P. A. ., & Sutiawan, I. S. . (2024). Platelet-rich plasma for chronic ulcers. Intisari Sains Medis, 15(1), 114–121. https://doi.org/10.15562/ism.v15i1.1948

HTML
0

Total
0

Share

Search Panel

Adelia Martalova AJ
Google Scholar
Pubmed
ISM Journal


I Gusti Ayu Agung Praharsini
Google Scholar
Pubmed
ISM Journal


Alfred Setyono
Google Scholar
Pubmed
ISM Journal


Putu Akopita Devi
Google Scholar
Pubmed
ISM Journal


Indry Salonika Sutiawan
Google Scholar
Pubmed
ISM Journal